Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, South Korean Institute Collaborate on Neurometabolomics Research

NEW YORK (GenomeWeb News) – Agilent Technologies and South Korea's Daegu Gyeongbuk Institute of Science and Technology (DGIST) today announced a collaboration focused on neurometabolomics research.

The collaboration kicked off with the opening of DGIST's new Neurometabolomics Excellence Research Center, which will use bioanalytical instruments from Agilent in its research directed at biomarkers for the early detection and diagnosis of brain diseases. Research conducted at the center will concentrate on changes in the metabolic materials of brain cells and their impact on the body's physiological functions and behaviors, Agilent said.

The center will be a hub for shared expertise, it added, including the research capabilities of the Johns Hopkins University Center for Metabolism and Obesity Research in the US, as well as major medical institutions and hospitals in Daegu.

Other neurometabolomics research projects planned at the center include those in the fields of medicine, neurobiology, statistics, computer science, and systems biology. There may also be opportunities for joint projects with major educational and medical institutions elsewhere in South Korea, as well as Singapore, and Australia, Agilent said.

Training and the development of scientists, researchers, and chemists will also be carried out at the center.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.